Peiqiang Cai
-
- Colorectal Cancer Surgical Treatments 14
- Colorectal Cancer Treatments and Studies 7
- Cancer Immunotherapy and Biomarkers 4
- Gastroenterology top 10%
-
- Gastric Cancer Management and Outcomes 9
-
- Colorectal and Anal Carcinomas 12
- Esophageal Cancer Research and Treatment 5
-
- Radiomics and Machine Learning in Medical Imaging 9
- Medical Imaging Techniques and Applications 3
- Journals
- Journal of Clinical Investigation (1 paper)Journal of Clinical Oncology (6 papers)Cancer Cell (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Peiqiang Cai
40 papers receiving 486 citations
Hit Papers
Peers
Comparison fields: 5 of 61
- Oncology 225
- Gastroenterology 32
- Cancer Research 71
- Hepatology 37
- Pulmonary and Respiratory Medicine 141
Countries citing papers authored by Peiqiang Cai
This map shows the geographic impact of Peiqiang Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peiqiang Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peiqiang Cai more than expected).
Fields of papers citing papers by Peiqiang Cai
This network shows the impact of papers produced by Peiqiang Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peiqiang Cai. The network helps show where Peiqiang Cai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peiqiang Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 2 | |
| 7 | Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 studybreakdown → | 2023 | 77 |
| 8 | 2023 | 17 | |
| 9 | 2023 | 5 | |
| 10 | 2022 | 18 | |
| 11 | 2022 | 1 | |
| 12 | 2021 | 11 | |
| 13 | 2021 | 13 | |
| 14 | 2021 | 18 | |
| 15 | 2017 | 9 | |
| 16 | 2016 | 14 | |
| 17 | 2016 | 2 | |
| 18 | 2015 | 7 | |
| 19 | 2015 | 8 | |
| 20 | 2010 | 10 |
About Peiqiang Cai
Peiqiang Cai is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 43 papers that have together received 490 indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (14 papers), Colorectal and Anal Carcinomas (12 papers), Gastric Cancer Management and Outcomes (9 papers), Radiomics and Machine Learning in Medical Imaging (9 papers), Colorectal Cancer Treatments and Studies (7 papers), Esophageal Cancer Research and Treatment (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Medical Imaging Techniques and Applications (3 papers). The work is most often cited by research in Oncology (225 citations), Gastroenterology (32 citations) and Cancer Research (71 citations). Peiqiang Cai has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Weiwei Xiao, Xiaofei Lv, Zhizhong Pan, Yi Fan, Ying Jin, Min Liu, Rui‐Hua Xu, Junzhong Lin, Gong Chen and Yanqing Gong. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.